146 related articles for article (PubMed ID: 37894264)
1. Detection and Quantification of the Epstein-Barr Virus in Lymphoma Patients from Ethiopia: Molecular and Serological Approaches.
Teshome S; Zealiyas K; Abubeker A; Tadesse F; Balakrishna J; Weigel C; Abebe T; Ahmed EH; Baiocchi RA
Microorganisms; 2023 Oct; 11(10):. PubMed ID: 37894264
[TBL] [Abstract][Full Text] [Related]
2. The Burden of Epstein-Barr Virus (EBV) and Its Determinants among Adult HIV-Positive Individuals in Ethiopia.
Zealiyas K; Teshome S; Berhe N; Amogne W; Haile AF; Abate E; Yimer G; Weigel C; Ahmed EH; Abebe T; Baiocchi R
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632085
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen.
Persson Berg L; Thomsson E; Hasi G; Bäckström M; Bergström T
J Virol Methods; 2020 Oct; 284():113927. PubMed ID: 32650039
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
5. Genotypes Distribution of Epstein-Barr Virus among Lymphoma Patients in Ethiopia.
Teshome S; Ahmed EH; Zealiyas K; Abubeker A; Tadesse F; Weigel C; Baiocchi RA; Abebe T
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762195
[TBL] [Abstract][Full Text] [Related]
6. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
7. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
[TBL] [Abstract][Full Text] [Related]
8. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
[TBL] [Abstract][Full Text] [Related]
9. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics.
Orem J; Sandin S; Mbidde E; Mangen FW; Middeldorp J; Weiderpass E
J Med Virol; 2014 Oct; 86(10):1796-803. PubMed ID: 24889739
[TBL] [Abstract][Full Text] [Related]
11. Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye.
Lay ML; Lucas RM; Ratnamohan M; Taylor J; Ponsonby AL; Dwyer DE;
Virol J; 2010 Sep; 7():252. PubMed ID: 20860842
[TBL] [Abstract][Full Text] [Related]
12. A three year Seroepidemiological and molecular study of Epstein -Barr virus infection among different age groups with hematological malignancies in a Tertiary care centre of North India ( 2017 -2019).
Patel SS; Singh S; Sahu C; Ghoshal U; Verma H
J Family Med Prim Care; 2021 Jan; 10(1):373-377. PubMed ID: 34017756
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus infection and risk of lymphoma: immunoblot analysis of antibody responses against EBV-related proteins in a large series of lymphoma subjects and matched controls.
de Sanjosé S; Bosch R; Schouten T; Verkuijlen S; Nieters A; Foretova L; Maynadié M; Cocco PL; Staines A; Becker N; Brennan P; Benavente Y; Boffetta P; Meijer CJ; Middeldorp JM
Int J Cancer; 2007 Oct; 121(8):1806-12. PubMed ID: 17557295
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.
Liu W; Li H; Sheng H; Liu X; Chi P; Wang X; Mao M
Adv Ther; 2020 Oct; 37(10):4280-4290. PubMed ID: 32780356
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
16. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
17. A hospital based pilot study on Epstein-Barr virus in suspected infectious mononucleosis pediatric patients in India.
Janani MK; Malathi J; Appaswamy A; Singha NR; Madhavan HN
J Infect Dev Ctries; 2015 Oct; 9(10):1133-8. PubMed ID: 26517489
[TBL] [Abstract][Full Text] [Related]
18. Genotype characterization of Epstein-Barr virus among adults living with human immunodeficiency virus in Ethiopia.
Zealiyas K; Teshome S; Haile AF; Weigel C; Alemu A; Amogne W; Yimer G; Abebe T; Berhe N; Ahmed EH; Baiocchi RA
Front Microbiol; 2023; 14():1270824. PubMed ID: 38029140
[TBL] [Abstract][Full Text] [Related]
19. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
